The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide: HPV in Anal Cancers
Open accessAbstract
Knowledge about human papillomaviruses (HPV) types involved in anal cancers in some world regions is scanty. Here, we describe the HPV DNA prevalence and type distribution in a series of invasive anal cancers and anal intraepithelial neoplasias (AIN) grades 2/3 from 24 countries. We analyzed 43 AIN 2/3 cases and 496 anal cancers diagnosed from 1986 to 2011. After histopathological evaluation of formalin-fixed paraffin-embedded samples, HPV DNA detection and genotyping was performed using SPF-10/DEIA/LiPA25 system (version 1). A subset of 116 cancers was further tested for p16(INK4a) expression, a cellular surrogate marker for HPV-associated transformation. Prevalence ratios were estimated using multivariate Poisson regression with robust variance in the anal cancer data set. HPV DNA was detected in 88.3% of anal cancers (95% confidence interval [CI]: 85.1-91.0%) and in 95.3% of AIN 2/3 (95% CI: 84.2-99.4%). Among cancers, the highest prevalence was observed in warty-basaloid subtype of squamous cell carcinomas, in younger patients and in North American geographical region. There were no statistically significant differences in prevalence by gender. HPV16 was the most frequent HPV type detected in both cancers (80.7%) and AIN 2/3 lesions (75.4%). HPV18 was the second most common type in invasive cancers (3.6%). p16(INK4a) overexpression was found in 95% of HPV DNA-positive anal cancers. In view of the results of HPV DNA and high proportion of p16(INK4a) overexpression, infection by HPV is most likely to be a necessary cause for anal cancers in both men and women. The large contribution of HPV16 reinforces the potential impact of HPV vaccines in the prevention of these lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
Barros, A. J., & Hirakata, V. N. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-21 · Cited by 4,140
de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728
Self-citationGlobal burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,534
Li, N., Franceschi, S., Howell‐Jones, R., Snijders, P. J. F., & Clifford, G. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.25396 · Cited by 1,066
Klaes, R., Friedrich, T., Spitkovsky, D., Ridder, R., Rudy, W., Petry, U., Dallenbach-Hellweg, G., Schmidt, D., & von Knebel Doeberitz, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1174 · Cited by 1,035
De Vuyst, H., Clifford, G. M., Nascimento, M. C., Madeleine, M. M., & Franceschi, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24116 · Cited by 966
Guan, P., Howell‐Jones, R., Li, N., Bruni, L., de Sanjosé, S., Franceschi, S., & Clifford, G. M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27485 · Cited by 927
Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer
Daling, J. R., Madeleine, M. M., Johnson, L. G., Schwartz, S. M., Shera, K. A., Wurscher, M. A., Carter, J. J., Porter, P. L., Galloway, D. A., & McDougall, J. K. (2004) · Cancer · doi:10.1002/cncr.20365 · Cited by 822
A review of clinical trials of human papillomavirus prophylactic vaccines
Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.108 · Cited by 747
Self-citationSexually Transmitted Infection as a Cause of Anal Cancer
Frisch, M., Glimelius, B., van den Brule, A. J. C., Wohlfahrt, J., Meijer, C. J. L. M., Walboomers, J. M. M., Goldman, S., Svensson, C., Adami, H.-O., & Melbye, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371904 · Cited by 701
Kleter, B., van Doorn, L.-J., Schrauwen, L., Molijn, A., Sastrowijoto, S., ter Schegget, J., Lindeman, J., ter Harmsel, B., Burger, M., & Quint, W. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.8.2508-2517.1999 · Cited by 655
Self-citationBray, F., Ferlay, J., Laversanne, M., Brewster, D. H., Gombe Mbalawa, C., Kohler, B., Piñeros, M., Steliarova‐Foucher, E., Swaminathan, R., Antoni, S., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29670 · Cited by 643
Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America
Silverberg, M. J., Lau, B., Justice, A. C., Engels, E., Gill, M. J., Goedert, J. J., Kirk, G. D., D'Souza, G., Bosch, R. J., Brooks, J. T., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir1012 · Cited by 520
Kleter, B., van Doorn, L.-J., ter Schegget, J., Schrauwen, L., van Krimpen, K., Burger, M., ter Harmsel, B., & Quint, W. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65688-x · Cited by 509
Self-citationHerfs, M., Yamamoto, Y., Laury, A., Wang, X., Nucci, M. R., McLaughlin-Drubin, M. E., Münger, K., Feldman, S., McKeon, F. D., Xian, W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202684109 · Cited by 437
Koshiol, J., Lindsay, L., Pimenta, J. M., Poole, C., Jenkins, D., & Smith, J. S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn036 · Cited by 428
de Sanjosé, S., Alemany, L., Ordi, J., Tous, S., Alejo, M., Bigby, S. M., Joura, E. A., Maldonado, P., Laco, J., Bravo, I. G., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.033 · Cited by 394
Self-citationHuman papillomavirus-related disease in people with HIV
Palefsky, J. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32831a7246 · Cited by 209
Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study
Abramowitz, L., Jacquard, A., Jaroud, F., Haesebaert, J., Siproudhis, L., Pradat, P., Aynaud, O., Leocmach, Y., Soubeyrand, B., Dachez, R., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25671 · Cited by 175
Diamond, C., Taylor, T. H., Aboumrad, T., Bringman, D., & Anton-Culver, H. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000162366.60245.02 · Cited by 164
The epidemiology of anal cancer
Grulich, A. E., Poynten, I. M., Machalek, D. A., Jin, F., Templeton, D. J., & Hillman, R. J. (2012) · Sexual Health · doi:10.1071/sh12070 · Cited by 159
Halec, G., Alemany, L., Lloveras, B., Schmitt, M., Alejo, M., Bosch, F. X., Tous, S., Klaustermeier, J. E., Guimerà, N., Grabe, N., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4405 · Cited by 139
Self-citationBiological activity of probable/possible high‐risk human papillomavirus types in cervical cancer
Halec, G., Schmitt, M., Dondog, B., Sharkhuu, E., Wentzensen, N., Gheit, T., Tommasino, M., Kommoss, F., Bosch, F. X., Franceschi, S., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27605 · Cited by 137
Self-citationHalec, G., Holzinger, D., Schmitt, M., Flechtenmacher, C., Dyckhoff, G., Lloveras, B., Höfler, D., Bosch, F. X., & Pawlita, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.296 · Cited by 110
Self-citationGuimerà, N., Lloveras, B., Lindeman, J., Alemany, L., van de Sandt, M. M., Alejo, M., Hernandez-Suarez, G. A., Bravo, I. G., Molijn, A. C., Jenkins, D., et al. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31828b6be4 · Cited by 110
Self-citationCornall, A. M., Roberts, J. M., Garland, S. M., Hillman, R. J., Grulich, A. E., & Tabrizi, S. N. (2013) · International Journal of Cancer · doi:10.1002/ijc.28228 · Cited by 99
The increasing incidence of anal cancer: can it be explained by trends in risk groups?
van der Zee, R. P., Richel, O., de Vries, H. J. C., & Prins, J. M. (2013) · PubMed · Cited by 94
Geraets, D. T., Alemany, L., Guimerà, N., de Sanjosé, S., de Koning, M. N. C., Molijn, A. C., Jenkins, D., Bosch, F. X., Quint, W. G. V., & on behalf of the RIS HPV TT Study Group (2012) · The Journal of Pathology · doi:10.1002/path.4065 · Cited by 70
Self-citationSignature patterns of human papillomavirus type 16 in invasive anal carcinoma
Valmary‐Degano, S., Jacquin, É., Prétet, J., Monnien, F., Girardo, B., Arbez‐Gindre, F., Joly, M. O., Bosset, J.-F., Kantelip, B. M., & Mougin, C. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.08.019 · Cited by 57
Steinau, M., Unger, E. R., Hernandez, B. Y., et al. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31827ed372 · Cited by 48
Self-citationHuman papillomavirus type 16 DNA in anal cancers from six different countries.
Scholefield, J. H., Kerr, I. B., Shepherd, N. A., Miller, K., Bloomfield, R., & Northover, J. M. A. (1991) · Gut · doi:10.1136/gut.32.6.674 · Cited by 28
Richel, O., Quint, K. D., Lindeman, J., van Noesel, C. J. M., de Koning, M. N. C., van den Munckhof, H. A. M., de Vries, H. J. C., Prins, J. M., & Quint, W. G. V. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu052 · Cited by 25
Self-citation
Cited by
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Marth, C., Landoni, F., Mahner, S., McCormack, M., Gonzalez-Martin, A., & Colombo, N. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx220 · Cited by 1,073
Carcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Self-citationUS Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
Saraiya, M., Unger, E. R., Thompson, T. D., Lynch, C. F., Hernandez, B. Y., Lyu, C. W., Steinau, M., Watson, M., Wilkinson, E. J., Hopenhayn, C., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv086 · Cited by 761
Self-citationHPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients
Castellsagué, X., Alemany, L., Quer, M., Halec, G., Quirós, B., Tous, S., Clavero, O., Alòs, L., Biegner, T., Szafarowski, T., et al. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv403 · Cited by 740
Self-citationThe natural history of human papillomavirus infection
de Sanjosé, S., Brotons, M., & Pavón, M. A. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.08.015 · Cited by 589
Self-citation
Metadata
- Authors
- Alemany, L., Saunier, M., Alvarado-Cabrero, I., Quirós, B., Salmeron, J., Shin, H.-R., Pirog, E. C., Guimerà, N., Hernandez-Suarez, G., Felix, A., Clavero, O., Lloveras, B., Kasamatsu, E., Goodman, M. T., Hernandez, B. Y., Laco, J., Tinoco, L., Geraets, D. T., Lynch, C. F., Mandys, V., Poljak, M., Jach, R., Verge, J., Clavel, C., Ndiaye, C., Klaustermeier, J., Cubilla, A., Castellsagué, X., Bravo, I. G., Pawlita, M., Quint, W. G., Muñoz, N., Bosch, F. X., de Sanjosé, S., & on behalf of the HPV VVAP Study Group
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2014-05-30
- Volume
- 136
- Issue
- 1
- Pages
- 98-107
- ISSN
- 0020-7136 (ISSN-L)
- OpenAlex
- W1543806678
- Cited by
- 388
- References
- 33
- FWCI
- 27.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.